Candriam Equities L Biotechnology Class I GBP CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/06/2024 |
|
Annual Returns (GBP) | 30/06/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/06 | |
Price Return | 16.06 | -4.56 | 28.66 | 17.29 | -1.63 | 9.66 | 1.50 | 6.80 |
+/- Category | 5.77 | 3.41 | 8.46 | -8.68 | 7.40 | 17.50 | 2.79 | 7.35 |
+/- Category Index | 0.87 | -2.71 | 11.95 | -15.65 | -1.93 | 7.20 | -5.83 | -11.06 |
% Rank in Category | 22 | 32 | 14 | 61 | 35 | 3 | 30 | 19 |
Trailing Returns (GBP) | 12/07/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.40 | 0.07 | 0.68 |
1 Week | 5.58 | -0.22 | 4.60 |
1 Month | 6.54 | 3.69 | 4.64 |
3 Months | 10.43 | 7.56 | -1.13 |
6 Months | 7.60 | 5.80 | -8.55 |
YTD | 10.77 | 8.75 | -7.15 |
1 Year | 21.93 | 11.45 | -14.42 |
3 Years Annualised | 6.75 | 10.03 | -1.78 |
5 Years Annualised | 9.96 | 2.58 | -2.92 |
10 Years Annualised* | 15.64 | 5.63 | 3.59 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/06/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.71 | 2.98 | - | - |
2023 | -5.08 | -0.50 | -0.62 | 8.13 |
2022 | -4.89 | -0.25 | 12.79 | 2.48 |
2021 | -5.73 | 6.89 | 0.69 | -3.04 |
2020 | -4.92 | 25.51 | -5.56 | 4.07 |
2019 | 13.85 | 1.54 | -5.89 | 18.26 |
|
Advertisement |